🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 multinational, randomized, double-blind study is designed to c...
Status
Completed
Location
The University of Arizona Cancer Centre-North Campus
Start Date
2017-06-19
Trial ID
NCT03112174
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of PCI-327...
Status
Completed
Location
Multiple Locations
Start Date
2014-01-31
Trial ID
NCT01974440
The purpose of this study is to assess the safety and tolerability of ibrut...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02271438
Treatments Being Tested
This is a multicenter, 2-cohort Phase 2 study assessing both minimal residu...
Status
Completed
Location
City of Hope /ID# 1142-0047
Start Date
2016-09-28
Trial ID
NCT02910583
Treatments Being Tested
The purpose of this study is to examine the safety and efficacy of Ibrutini...
Status
Completed
Location
Multiple Locations
Start Date
2012-09-19
Trial ID
NCT01611090
Treatments Being Tested
The purpose of this study is to evaluate if ibrutinib administered in combi...
Status
Completed
Location
Multiple Locations
Start Date
2013-09-03
Trial ID
NCT01855750
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multicenter Phase 3...
Status
Completed
Location
Southern Cancer Center
Start Date
2017-01-23
Trial ID
NCT02947347
Treatments Being Tested